Filter articles using the following links

Ophthalmology Futures Retina – Virtual Forum

Chardan 4th Annual Genetic Medicines Conference – Virtual

GenSight Biologics Announces Publication of Meta-Analysis Confirming that Spontaneous Recovery in LHON is rare in the Journal of Neuro-Ophthalmology

GenSight Biologics reports new analysis demonstrating statistically significant and clinically meaningful difference between visual outcomes in LUMEVOQ®-treated patients and natural history of Leber Hereditary Optic Neuropathy (LHON)

GenSight Biologics Submits EU Marketing Authorisation Application for LUMEVOQ® Gene Therapy to Treat Vision Loss due to Leber Hereditary Optic Neuropathy (LHON)

H.C. Wainwright 22nd Annual Global Investment Conference – Virtual Conference

OIS Retina Innovation Showcase

GenSight Biologics draws down the €4 million second tranche of bonds from Kreos Capital

UMDF Power Surge 2020 – online event

2020 Annual Scientific Meeting ASRS – Virtual format